2020-12-22,Top Small Cap Stocks for January 2021
2020-11-29,Is XBiotech Inc. (XBIT) A Good Stock To Buy?
2020-11-19,XBiotech Data Shows Effective Anti-Virus Activity for True Human Antibodies in Its Candidate Influenza-COVID-19 Therapeutic Cocktail
2020-09-22,What Kind Of Shareholders Hold The Majority In XBiotech Inc.'s (NASDAQ:XBIT) Shares?
2020-09-21,XBiotech Developing True Human Antibody Combination as Candidate Treatment for Influenza-COVID-19 Co-Infections
2020-09-15,Top Biotech Stocks for Q4 2020
2020-08-24,Here's How I'm Trading XBiotech
2020-08-24,XBiotech-Developed COVID-19 Test Supports Convalescent Blood Treatments Now Approved Under FDA Emergency Use Authorization
2020-08-17,XBiotech Discovers COVID-19 Candidate Therapy
2020-07-22,XBiotech Achieves Milestone for Production of its New Potential Blockbuster Anti-IL-1 Therapy
2020-07-14,XBiotech Announces Discovery that Blocking Interleukin-1a Reduces Brain Injury and Neurological Deficit After Stroke
2020-06-22,Hedge Funds Starting To Get Bullish On XBiotech Inc. (XBIT)
2020-05-01,XBiotech Identifies Super Bloods for the Development of a True Human COVID-19 Therapy
2020-04-17,Could XBiotechs Convalescent Plasma Program Make a Breakthrough in Treating COVID-19 Patients?
2020-04-14,XBiotech Developing Novel True Human Antibody Targeting Interleukin-1alpha (IL-1)
2020-04-03,XBiotech and BioBridge Global Collaborate on FDA Program to Develop Potential COVID-19 Treatment Based on Natural Antibodies from Recovered Patients
2020-02-19,XBiotech Announces Final Results of Tender Offer
2020-02-13,Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer
2020-02-13,XBiotech Announces Preliminary Results of Tender Offer
2020-02-10,"$1.35B deal offers vindication, runway for Austin-based XBiotech"
2020-01-15,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance"
2020-01-14,"XBiotech Commences Tender Offer to Purchase up to $420,000,000 of its Shares"
2019-12-30,XBiotech Closes on Sale of True Human Antibody Bermekimab to Janssen
2019-12-20,XBiotech Inc. (XBIT): Are Hedge Funds Right About This Stock?
2019-12-17,XBiotech Added to NASDAQ Biotechnology Index
2019-12-10,Drug manufacturers have spent a record $342 billion on M&A in 2019
2019-12-07,XBiotech Announces Agreement to Sell True Human Antibody Bermekimab Targeting IL-1a to Janssen
2019-11-19,XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with Hidradenitis Suppurativa
2019-11-12,XBiotech Announces First Patient Enrolled in Placebo-Controlled Clinical Study Evaluating Its anti-IL-1 Therapy Bermekimab in Patients with Atopic Dermatitis (Eczema)
2019-10-23,XBiotech Announces First Patient Enrolled in Randomized Multi-Center Clinical Study Evaluating Bermekimab Therapy in Patients with Hidradenitis Suppurativa
2019-10-10,XBiotech (NASDAQ:XBIT) Is In A Good Position To Deliver On Growth Plans
2019-10-02,XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis
2019-09-27,"XBiotech Announces Oral Presentation of Atopic Dermatitis Results for Bermekimab at 2019 EADV Congress in Madrid, Spain"
2019-09-20,XBiotech Announces Granting of Canadian Patent for Treatment of Dermatological Pathologies
2019-07-16,What Kind Of Investor Owns Most Of XBiotech Inc. (NASDAQ:XBIT)?
2019-07-11,Dr. Seth Forman to Chair XBiotechs Second Phase 2 Study of Bermekimab in Atopic Dermatitis
2019-07-10,"XBiotech Adds Dr. Peter Libby, Renowned Cardiologist and Research Pioneer in Inflammation and Cardiovascular Disease, to its Corporate Board"
2019-07-09,Medical Research Council Funds Phase 2 Multi-Center Study of XBiotechs Bermekimab in Advanced Cancer Patients
2019-06-26,"XBiotech Wins Commercial Real Estate Award for Industrial Development for its Headquarters in Austin, Texas"
2019-06-25,XBiotech Announces Dr. Alice Gottlieb to Chair Upcoming Phase 2 Study of Bermekimab in Hidradenitis Suppurativa
2019-06-11,XBiotech Added to Russell 3000® Index
2019-06-04,XBiotech Announces Closing of Public Offering of Common Shares
2019-05-31,XBiotech Announces Pricing of Public Offering of Common Shares
2019-05-30,XBiotech Announces Public Offering of Common Shares
2019-05-23,XBiotech Announces Plan to Launch Randomized Phase 2b Study of Bermekimab in Hidradenitis Suppurativa
2019-05-13,5 Growthy Biotech Stocks to Buy Despite the Scrutiny
2019-05-02,"XBiotech Announces Enrollment Completion, Positive Findings for Bermekimab in Pancreatic Cancer Study"
2019-04-29,Read This Before Selling XBiotech Inc. (NASDAQ:XBIT) Shares
2019-03-04,How you should trade the biotech ETFs
2019-03-01,S&P has best two-month start to year since 1991
2019-03-01,"Breakthrough Results from Phase 2 Clinical Trial of Bermekimab in the Treatment of Atopic Dermatitis (AD) to be Presented on March 2, 2019 at American Academy of Dermatology Annual Meeting"
2019-02-07,You Should Be Selling XBiotech Stock After the Huge Gains
2019-02-06,These 4 Biotech Stocks Are Leading The Industry
2019-01-29,Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting
2019-01-28,Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual Meeting
2019-01-23,"Bermekimab Successfully Treats Hidradenitis Suppurativa, Including Significant Reduction in Pain"
2018-12-13,XBiotech Announces Publication of Post-Hoc Analysis for Phase III Colorectal Cancer Study
2018-12-12,XBiotechs Results from Phase 2 Atopic Dermatitis Study Suggest New Drug to Treat Skin Disease
2018-12-03,XBiotech Announces Successful Completion of GMP Audit
2018-11-23,"Detailed Research: Economic Perspectives on Jason Industries, XBiotech, Dynatronics, Evolving, CTI BioPharma, and Charles & Colvard  What Drives Growth in Today's Competitive Landscape"
2018-10-31,XBiotech Highlights Third Quarter Developments for 2018
2018-10-26,XBiotech Announces New Patents for Third Quarter 2018
2018-10-24,XBiotech Announces Dismissal of Securities Class Action Suit
2018-10-05,XBiotech Announces Enrollment Completion in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Atopic Dermatitis
2018-09-26,XBiotech Announces Granting of European Patent for Treatment of Inflammatory Skin Diseases
2018-09-24,XBiotech Announces Completion of U.S. Enrollment in Phase 2 Multicenter Study Evaluating Bermekimab in Patients with Hidradenitis Suppurativa
2018-09-20,XBiotech Announces Addition of Top Dermatologist and Researcher Dr. Alice Gottlieb to its Team
2018-09-13,XBiotech Announces Completion and Positive Interim Findings for Initial Cohort in Bermekimab Pilot Study in Atopic Dermatitis
2018-09-12,XBiotech Announces Addition of World Leading Cardiologist Dr. Peter Libby to its Scientific Advisory Board
2018-08-27,XBiotech Announces Publication of Breakthrough Findings for Potential Role of Interleukin-1 alpha in Risk for Heart Attacks
2018-08-10,XBiotech Highlights Quarterly Developments
2018-07-10,XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa
2018-07-10,XBiotech Announces First Patient in Phase 2 Study Evaluating Subcutaneous MABp1 in Patients with Hidradenitis Suppurativa
2018-05-22,XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis
2018-04-16,XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology
2018-04-02,XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer
2018-01-29,Blog Exposure - XBiotech To Present Data From Phase-2 Study On MABp1 For Treatment Of Hidradenitis Suppurativa at EHSF Conference
2018-01-26,XBiotech Announces Presentation of Data from Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
2018-01-25,XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus
2018-01-25,XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus
2018-01-22,Blog Exposure - XBiotech to Present Phase-2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa at EHSF Conference
2018-01-19,XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
2017-12-11,"The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by XBiotech, Inc."
2017-12-04,XBiotech Announces Publication of Phase 2 Data from Hidradenitis Suppurativa Phase 2 Study in The Journal of Investigative Dermatology
2017-11-17,"The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by XBiotech, Inc."
2017-11-16,"Lifshitz & Miller LLP Announces Investigation of CBBC Bancorp, Clifton Bancorp Inc., Dynegy, Inc., GenMark Diagnostics, Inc., Impax Laboratories, Inc., RPM International Inc. and XBiotech Inc."
2017-11-14,XBiotech Announces Presentation of Novel Findings for MABp1 in the Prevention of Coronary Thrombosis at the American Heart Association Scientific Sessions
2017-11-08,"XBIT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of XBiotech, Inc."
2017-11-03,XBiotech's MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific Sessions
2017-11-03,XBiotechs MABp1 to be Featured in Oral Presentation at the American Heart Association Scientific Sessions
2017-11-03,"XBIT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of XBiotech, Inc."
2017-11-02,"IMPORTANT XBIOTECH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Western District of Texas on behalf of investors who purchased and suffered losses in XBiotech, Inc."
2017-10-26,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Investors in XBiotech, Inc. and Set a Lead Plaintiff Deadline of December 26, 2017 -- XBIT"
2017-10-19,"INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc. -- XBIT"
2017-10-18,XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer
2017-10-03,XBiotech Announces Addition of Renowned Dermatologist Dr. William Levis to its Scientific Advisory Board
2017-09-21,XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference
2017-09-20,XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with Onivyde and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer
2017-09-18,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc."
2017-09-07,XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
